Company
Genrix (Shanghai) Biopharmaceutical Co., Ltd.
Genrix (Shanghai) Biopharmaceutical Co., Ltd. has 1 drug tracked on RxWires: 1 in Phase 2.
Pipeline
| Drug | Phase | Indication |
|---|---|---|
| GR2301 injection | Phase 2 | Vitiligo |
Latest
No recent events.
Follow Genrix (Shanghai) Biopharmaceutical Co., Ltd. on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.